Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Regulatory requirements, product complexity and diverse biological matrices present formidable bioanalytical challenges. Innovative use of bioanalytical technologies with improved measurement accuracy are key to overcoming challenges presented by the chemistry and biology of analytes.
During this webinar our experts will present a snapshot of several innovative and non-conventional bioanalysis techniques starting with the use of liquid chromatography (LC) - high resolution accurate mass spectrometry (HRAMS) based protein analyses. This toolset is increasingly needed for drug development, with notable strengths for biologics analyses and basic discovery including an increased understanding of biomarkers. An introduction to several non-conventional bioanalytical techniques will follow, including nuclear magnetic resonance spectroscopy (NMR), inductively coupled plasma-mass spectrometry (ICP-MS) and Selected Ion Flow Tube – Mass Spectrometry (SIFT-MS). These non-conventional approaches are part of a diverse range of analytical techniques that are being utilized at Intertek to meet the demands of increasing complex bioanalytical challenges.
Time / Date: Wed 6 June 2018 at 16:00 BST / 08:00 PDT
Larry Brill, Senior Scientist, Protein and Bioanalytical LCMS, Anthony Upton, Bioanalytical Laboratory Manager, Europe, Joseph Wicks, Senior Scientist, Intertek Pharmaceutical Services. This webinar was pre-recorded on 20 April 2018